Edwards
ForeSight Brain Oxygenation Sensors FDA
Cleared to
Pair with Hemosphere Monitor
Edwards Lifesciences won FDA clearance to integrate its
ForeSight Brain tissue oxymetry
Sensors with the
Hemosphere monitoring platform. While the clearance is really for a connecting cable, the capability allows anesthesiologists to monitor the oxygen saturation of the
Brain during surgeries and to correlate it
with hemodynamic parameters in real-time.
“Understanding the relationship between the heart and the
Brain can provide valuable patient insights to support decision making during a surgical procedure,” said Katie Szyman, corporate vice president of critical care at Edwards. “With the addition of the
ForeSight Sensors to Edwards’ most modern platform, HemoSphere, we can offer clinicians a broad range of smart hemodynamic management solutions to help improve patient care.”
The
Sensors rely on near-infrared spectroscopy to penetrate through the scalp and measure the oxygen content on the other side. One important feature of the
Hemosphere system that the
ForeSight Sensors work
with is that it offers clinicians the ability to predict many cases of unexpected blood pressure drops, allowing for timely intervention during procedures.
Flashback:
Edwards HemoSphere Hemodynamic Monitoring System Cleared by FDA
Product page:
Edwards ForeSight tissue oximetry sensors…
Via:
Edwards
